Inogen Inc
INGN6.540USD
+0.330+5.31%
Market hours （ET）Quotes delayed by 15 min
175.84MMarket Cap
LossP/E TTM
More Details of Inogen Inc Company
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.
Company Info
Ticker SymbolINGN
Company nameInogen Inc
IPO dateFeb 14, 2014
CEOMr. Kevin R. M. Smith
Number of employees766
Security typeOrdinary Share
Fiscal year-endFeb 14
Address859 Ward Drive
CityGOLETA
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code93111
Phone18055620500
Websitehttps://www.inogen.com/
Ticker SymbolINGN
IPO dateFeb 14, 2014
CEOMr. Kevin R. M. Smith
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+125.45%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+125.45%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
47.65K
--
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
--
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.62K
--
Ms. Jennifer Boyer
Ms. Jennifer Boyer
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
--
--
Mr. Kevin P. Smith
Mr. Kevin P. Smith
Executive Vice President - Business Development, General Counsel, Secretary
Executive Vice President - Business Development, General Counsel, Secretary
--
--
Ms. Elizabeth (Beth) Mora, CPA
Ms. Elizabeth (Beth) Mora, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kevin R. M. Smith
Mr. Kevin R. M. Smith
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Mary Katherine (Kay) Ladone
Ms. Mary Katherine (Kay) Ladone
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+125.45%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+125.45%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
47.65K
--
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
--
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.62K
--
Ms. Jennifer Boyer
Ms. Jennifer Boyer
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
No Data
By RegionUSD
Name
Revenue
Proportion
U.S. revenue
50.30M
61.13%
Non-U.S. revenue
31.98M
38.87%
By Business
By Region
No Data
Shareholding Stats
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.77%
BlackRock Institutional Trust Company, N.A.
5.88%
The Vanguard Group, Inc.
5.73%
Acadian Asset Management LLC
3.82%
Kent Lake PR LLC
3.73%
Other
71.07%
Shareholders
Shareholders
Proportion
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.77%
BlackRock Institutional Trust Company, N.A.
5.88%
The Vanguard Group, Inc.
5.73%
Acadian Asset Management LLC
3.82%
Kent Lake PR LLC
3.73%
Other
71.07%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
27.40%
Investment Advisor
24.68%
Hedge Fund
15.65%
Corporation
9.77%
Research Firm
2.29%
Individual Investor
2.23%
Family Office
0.84%
Sovereign Wealth Fund
0.41%
Pension Fund
0.38%
Other
16.34%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
327
22.70M
84.43%
-2.24M
2025Q1
372
22.71M
84.47%
-2.93M
2024Q4
375
21.79M
82.19%
-5.25M
2024Q3
367
21.78M
91.28%
-6.90M
2024Q2
360
23.19M
97.91%
-6.59M
2024Q1
364
22.78M
97.44%
-4.92M
2023Q4
369
22.26M
95.31%
-4.56M
2023Q3
386
22.05M
94.85%
-5.76M
2023Q2
403
22.24M
96.20%
-5.90M
2023Q1
403
23.45M
102.09%
-2.61M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
2.63M
9.77%
+2.63M
--
Feb 21, 2025
BlackRock Institutional Trust Company, N.A.
1.58M
5.88%
-16.61K
-1.04%
Mar 31, 2025
The Vanguard Group, Inc.
1.54M
5.73%
+82.64K
+5.67%
Mar 31, 2025
Acadian Asset Management LLC
1.03M
3.82%
+270.45K
+35.69%
Mar 31, 2025
Kent Lake PR LLC
1.00M
3.73%
+417.04K
+71.10%
Mar 31, 2025
Camber Capital Management LP
975.00K
3.63%
-1.02M
-51.25%
Mar 31, 2025
Columbia Threadneedle Investments (US)
874.53K
3.25%
+25.55K
+3.01%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
757.12K
2.82%
+149.28K
+24.56%
Mar 31, 2025
Renaissance Technologies LLC
730.80K
2.72%
+237.90K
+48.27%
Mar 31, 2025
Geode Capital Management, L.L.C.
570.42K
2.12%
+17.82K
+3.23%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Invesco NASDAQ Future Gen 200 ETF
0.49%
Cultivar ETF
0.44%
Federated Hermes MDT Small Cap Core ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.12%
Vanguard US Multifactor ETF
0.1%
Vanguard US Momentum Factor ETF
0.05%
iShares Micro-Cap ETF
0.04%
Vanguard US Quality Factor ETF
0.03%
Avantis US Small Cap Equity ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
View more
Invesco NASDAQ Future Gen 200 ETF
Proportion0.49%
Cultivar ETF
Proportion0.44%
Federated Hermes MDT Small Cap Core ETF
Proportion0.25%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.12%
Vanguard US Multifactor ETF
Proportion0.1%
Vanguard US Momentum Factor ETF
Proportion0.05%
iShares Micro-Cap ETF
Proportion0.04%
Vanguard US Quality Factor ETF
Proportion0.03%
Avantis US Small Cap Equity ETF
Proportion0.02%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.02%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
